share_log

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session

爲什麼Ultragenyx製藥股價下跌了約9%?以下是週一午盤交易中其他股票的走勢
Benzinga ·  04/15 14:11
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) fell sharply during Monday's session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic disorder causing developmental disabilities and nerve-related symptoms.
Ultragenyx Pharmaceutical Inc.(納斯達克股票代碼:RARE)的股價在週一的交易中大幅下跌,此前該公司公佈了針對Angelman綜合徵的1/2期研究的新數據,安傑爾曼綜合徵是一種導致發育障礙和神經相關症狀的遺傳性疾病。GTX-102
Ultragenyx Pharmaceutical shares dipped 9.4% to $42.46 on Monday.
週一,Ultragenyx Pharmaceutical股價下跌9.4%,至42.46美元。
Here are some other stocks moving in today's mid-day session.
以下是今天中午交易時段中其他一些走勢的股票。
Gainers
獲勝者
Soligenix, Inc. (NASDAQ:SNGX) shares surged 71.5% to $0.6679 after the company announced that it was granted orphan drug designation to the active ingredient in MarVax for the prevention and post-exposure prophylaxis against MARV infection by the FDA. Longeveron Inc. (NASDAQ:LGVN) surged...
Soligenix, Inc.(納斯達克股票代碼:SNGX)股價飆升71.5%,至0...
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論